Insiders Abbott Laboratories

Equities

Market Closed - Nyse Other stock markets 01:00:02 2024-07-03 pm EDT			5-day change	1st Jan Change
102.3 ^USD	-0.84%		-2.43%	-7.03%

Jul. 02	Evercore ISI Adjusts Price Target on Abbott Laboratories to $120 From $125, Maintains Outperform Rating	MT
Jul. 01	Abbott Laboratories(NYSE:ABT) dropped from Russell 3000E Growth Index	CI

U.S. FDA set to reorganize its food division starting October	May. 30	RE
Abbott Laboratories Insider Sold Shares Worth $2,428,119, According to a Recent SEC Filing	May. 08	MT
Abbott Laboratories Announces Retirement of Robert E. Funck, Jr as Executive Vice President, Finance, Effective July 1, 2024	May. 01	CI
AbbVie CEO to Retire; COO Robert Michael Named Successor	Feb. 20	MT
AbbVie Names Robert Michael to Succeed Richard Gonzalez as CEO	Feb. 20	DJ
Abbott Laboratories Insider Sold Shares Worth $1,620,000, According to a Recent SEC Filing	Dec. 18	MT
NeuroOne Medical Technologies Names Christopher Volker as Chief Operating Officer	Nov. 15	MT
Abbott Laboratories Insider Sold Shares Worth $4,702,526, According to a Recent SEC Filing	23-10-30	MT
Insider Sell: Abbott Laboratories	23-08-11	MT
Insider Sell: Abbott Laboratories	23-07-28	MT
Abbott Laboratories Names Philip Boudreau Finance Chief	23-06-12	MT
Abbott Laboratories Announces Management Changes, Effective September 1, 2023	23-06-12	CI
Insider Sell: Abbott Laboratories	23-05-03	MT
Insider Sell: Abbott Laboratories	23-01-03	MT
STAAR Surgical CEO Caren Mason to Retire, Thomas Frinzi Named Successor	22-12-19	MT
Insider Sell: Abbott Laboratories	22-12-15	MT
Insider Sell: Abbott Laboratories	22-09-09	MT
Insider Sell: Abbott Laboratories	22-08-26	MT
Abbott Laboratories Announces Executive Changes	22-08-01	CI
Insider Sell: Abbott Laboratories	22-07-28	MT

No results for this search